Search

Search Constraints

You searched for: Author/Creator Hayakawa, Yuka

Search Results

1. Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B. Issue 1 (4th October 2022)

2. Azilsartan attenuates cardiac damage caused by high salt intake through the downregulation of the cardiac (pro)renin receptor and its downstream signals in spontaneously hypertensive rats. Issue 11 (November 2018)

3. Changes of liver stiffness measured by magnetic resonance elastography during direct‐acting antivirals treatment in patients with chronic hepatitis C. Issue 6 (28th September 2020)

4. Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis B. Issue 8 (7th February 2020)

5. Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment. Issue 5 (21st April 2022)

6. Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment. Issue 5 (10th February 2021)

7. Early radiological response evaluation with response evaluation criteria in solid tumors 1.1 stratifies survival in hepatocellular carcinoma patients treated with lenvatinib. Issue 6 (16th October 2020)

8. Hepatitis B core‐related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen‐negative chronic hepatitis B patients. Issue 10 (16th June 2021)

9. Hepatitis B surface antigen reduction as a result of switching from long‐term entecavir administration to tenofovir. Issue 3 (24th October 2019)

10. Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease. Issue 10 (8th July 2021)